share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:擬議出售證券
SEC announcement ·  04/05 22:28
牛牛AI助理已提取核心訊息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/05/2024, as per the latest filing. The shares, valued at an aggregate market value of $4,206.08, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $311,765.76. The planned sale is in line with the notice dated 04/05/2024, and the plan for this transaction was adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/05/2024, as per the latest filing. The shares, valued at an aggregate market value of $4,206.08, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $311,765.76. The planned sale is in line with the notice dated 04/05/2024, and the plan for this transaction was adopted on 03/14/2023.
根據最新文件,Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年5月4日出售該公司的3,968股A類股票。這些股票的總市值爲4,206.08美元,最初於2022年7月10日作爲限制性股票歸屬的一部分收購,是對向發行人提供的服務的補償。該交易是在過去三個月進行了一系列銷售之後進行的,共出售了246,016股股票,總收益約爲311,765.76美元。計劃中的出售與2024年5月4日的通知一致,該交易的計劃於2023年3月14日獲得通過。
根據最新文件,Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年5月4日出售該公司的3,968股A類股票。這些股票的總市值爲4,206.08美元,最初於2022年7月10日作爲限制性股票歸屬的一部分收購,是對向發行人提供的服務的補償。該交易是在過去三個月進行了一系列銷售之後進行的,共出售了246,016股股票,總收益約爲311,765.76美元。計劃中的出售與2024年5月4日的通知一致,該交易的計劃於2023年3月14日獲得通過。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。